Brief: Sequana Medical: Results From Red DESERT alfapump DSR Study

Sequana Medical NV

11/05/2021 06:11

May 11 (Reuters) - SEQUANA MEDICAL NV  SEQUA.BR :
    * ANNOUNCES STRONG TOP-LINE RESULTS FROM RED DESERT ALFAPUMP
DSR®
STUDY AND EXPANSION OF DSR® DEVELOPMENT PROGRAMME
    * SAHARA DESERT STUDY IN HEART FAILURE PATIENTS WITH
RESIDUAL
CONGESTION TO START IN Q2 2021
    * RED DESERT DATA OF ALL PATIENTS CONFIRM: ALFAPUMP DSR IS
HIGHLY
EFFECTIVE AT MANAGING FLUID AND SODIUM BALANCE IN
DIURETIC-RESISTANT HEART FAILURE PATIENTS WITHOUT NEED FOR LOOP
DIURETICS

Source text for Eikon:  ID:nGNE2fjYHp 
Further company coverage:  SEQUA.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))